Managing Executive

PSI South Africa

Guata Mavundla has over 20 years of proven experience at top multinational companies within the South African healthcare and pharmaceutical industrie, including MSD Pharma, Bristol Myers Squibb Pharmaceuticals, Sanofi, Sandoz and Abbott Pharmaceutical.  His experience spans across multiple organizational functions, including as a director, in general management, sales, marketing, commercial operations and leading support functions. Mr. Mavundla has worked closely with stakeholders in the healthcare and pharmaceutical industries, including policymakers, government leadership, medical insurers, the South African National Treasury and various healthcare providers within South Africa as well as anglophone and lusophone southern Africa.

Mr. Mavundla has also worked outside of the corporate health sector as a consultant for Cizani Holdings. During this time, he provided general consultation services for private healthcare entities that are seeking to establish or expan their geographic footprint on the African continent.

Mr. Mavundla’s areas of expertise include general management, sales, marketing, strategic planning and execution, communication and facilitation, financial management, leading through change, leading cross-functional teams, and engagement with healthcare legislature.


Discover what's happening at PSI

In Memoriam to Bill Gates, Sr.

By Karl Hofmann, President & CEO, PSI  Let me add our voices to those who have paid tribute to Bill Gates, Sr. His remarkable contributions to the work of

+ Read More

Youth Contraceptive Programming: Learning from a Mid-Term Evaluation

As a learning project, PSI’s flagship adolescent sexual and reproductive health program, Adolescents 360 (A360) used its external 2018 mid-term evaluation (MTE) to support corrections

+ Read More

Infected and Affected: The Indirect Consequences of COVID-19 in Central America

By Jennifer Wheeler, PSI Deputy Director, Research, Paola Letona, PSI Evidence Regional Director, LAC, and Sussy Lungo, Regional Executive Director, Asociación PASMO “When you are

+ Read More

Five Market Indicators that Signal the Hormonal IUS will take off

By Kendal Danna, PSI Technical Advisor, Reproductive Health  In 2017, with USAID support, PSI began piloting the introduction of the hormonal Intrauterine System (IUS), also

+ Read More

HIVST for Key populations: Experiences from West Africa, Asia and Southern Africa

More than four decades into the HIV epidemic, an estimated 21% of people with HIV, more than 8.1 million people, remain undiagnosed. HIV self-testing is

+ Read More

In Memoriam of Hildah Mbaya

By Karl Hofmann, President & CEO, Population Services International PSI is extremely sad to report the untimely death of our Country Representative in South Sudan, Hildah

+ Read More